Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry

Journal of Virological Methods

Volumn 145, Issue 2, 2007, Pages 106-114

  Morrissey, Bethny ^a   Streamer, Margaret ^a   Downard, Kevin M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antigenicity; Determinants; Influenza virus; Mass spectrometry; Protein interactions

Indexed keywords

HEMAGGLUTININ; MONOCLONAL ANTIBODY;

ANTIGENICITY; ARTICLE; INFLUENZA VIRUS A H3N2; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS ISOLATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MOLECULAR SEQUENCE DATA; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ORTHOMYXOVIRIDAE;

EID: 34347217120     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.05.015     Document Type: Article

References (33)

1. Alymova I.V., Kodihalli S., Govorkova E.A., Fanget B., Gerdil C., and Webster R.G. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs. J. Virol. 72 (1998) 4472-4477
2. Anton, A., Zoehner, A., Wolff, T., 2006. Direct Submission, NCBI nucleotide Database, Accession DQ487340.
3. Ben-Yedidia T., Beignon A.S., Partidos C.D., Muller S., and Arnon R. A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. Mol. Immunol. 39 (2002) 323-331
4. Centre for Disease Control and Prevention, 2006. Update: Influenza Activity-United States and Worldwide, 2005-06 Season, and Composition of the 2006-07 Influenza Vaccine. Morb. Mortal. Week. Report 55, 648-653.
5. Firestone S.M., Barr I.G., Roche P.W., and Walker J.C. Annual report of the National Influenza Surveillance Scheme, 2005. Commun. Dis. Intell. 30 (2006) 189-200
6. Garman E., and Laver G. Controlling influenza by inhibiting the virus's neuraminidase. Curr. Drug Targets 5 (2004) 119-136
7. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., and Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucl. Acids Res. 31 (2003) 3784-3788
8. Girard M.P., Cherian T., Pervikov Y., and Kieny M.P. A review of vaccine research and development: human acute respiratory infections. Vaccine 23 (2005) 5708-5724
9. Gubareva L.V., Kaiser L., and Hayden F.G. Influenza virus neuraminidase inhibitors. Lancet 355 (2000) 827-835
10. Huang X., and Miller W. A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 12 (1991) 337-357
11. Jin H., Zhou H., Liu H., Chan W., Adhikary L., Mahmood K., Lee M.S., and Kemble G. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336 (2005) 113-119
12. Kim C.U., Lew W., Williams M.A., Liu H., Zhang L., Swaminathan S., Bischofberger N., Chen M.S., Mendel D.B., Tai C.Y., Laver W.G., and Stevens R.C. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119 (1997) 681-690
13. Kiselar J.G., and Downard K.M. Antigenic surveillance of the influenza virus by mass spectrometry. Biochemistry 38 (1999) 14185-14191
14. Kiselar J.G., and Downard K.M. Direct identification of protein epitopes by mass spectrometry without immobilization of antibody and isolation of antibody-peptide complexes. Anal. Chem. 71 (1999) 1792-1801
15. Kiselar J.G., and Downard K.M. Preservation and detection of specific antibody--peptide complexes by matrix-assisted laser desorption ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 11 (2000) 746-750
16. Kodihalli S., Justewicz D.M., Gubareva L.V., and Webster R.G. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. J. Virol. 69 (1995) 4888-4897
17. Lazarowitz S.G., Compans R.W., and Choppin P.W. Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology 46 (1971) 830-843
18. Macken C., Lu H., Goodman J., and Boykin L. The value of a database in surveillance and vaccine selection. In: Osterhaus A.D.M.E., Cox N., and Hampson A.W. (Eds). Options for the Control of Influenza IV (2001), Elsevier Science, Amsterdam 103-106
19. Meijer A., Paget W.J., Meerhoff T.J., Brown C.S., Meuwissen L.E., and van der Velden J. Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winter. Euro. Surveill. 11 (2006) 111-118
20. Morrissey B., and Downard K.M. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry. Proteomics 6 (2006) 2034-2041
21. Muller G.M., Shapira M., and Arnon R. Anti-influenza response achieved by immunization with a synthetic conjugate. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 569-573
22. Patriarca P.A., and Cox N.J. Influenza pandemic preparedness plan for the United States. J. Infect. Dis. 176 Suppl. 1 (1997) S4-S7
23. Plotkin J.B., and Dushoff J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7152-7157
24. Skehel J.J. Polypeptide synthesis in influenza virus-infected cells. Virology 49 (1972) 23-36
25. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., and Fouchier R.A. Mapping the antigenic and genetic evolution of influenza virus. Science 305 (2004) 371-376
26. Stone R. Avian influenza. Combating the bird flu menace, down on the farm. Science 311 (2006) 944-946
27. Vareckova E., Mucha V., Wharton S.A., and Kostolansky F. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch. Virol. 148 (2003) 469-486
28. von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Van Phan T., Smythe M.L., White H.F., and Oliver S.W. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363 (1993) 418-423
29. Webster R.G., and Walker E.J. Influenza: the world is teetering on the edge of a pandemic that could kill a large fraction of the human population. Am. Sci. 91 (2003) 122
30. Wiley D.C., and Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56 (1987) 365-394
31. Wiley D.C., Wilson I.A., and Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
32. Wilson I.A., Skehel J.J., and Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289 (1981) 366-373
33. Yewdell J.W., Taylor A., Yellen A., Caton A., Gerhard W., and Bachi T. Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region. J. Virol. 67 (1993) 933-942